In radiotherapy resistance, PTBP1 promotes switching from DNMT3B‐S to DNMT3B‐L, suppressing DUSP2 and enhancing radioresistance in prostate cancer [303]. The gene discussed is DNMT3B; the disease is prostate cancer.